Overview

Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.

Status:
Unknown status

Trial end date:
2019-04-01

Target enrollment:

Participant gender:

Summary

This study is to evaluate the efficacy and safety of orally administered SA001 compared to placebo in patients with Dry Eye Syndrome .

Phase:

Phase 2

Details

Lead Sponsor:

Samjin Pharmaceutical Co., Ltd.